Remifentanil for fibre-optic intubation: Use in difficult airways

Anaesthesia

Volumn 64, Issue 2, 2009, Pages 220-

  Goodman, C T D ^a   Kessell, G ^a  

^a JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE; REMIFENTANIL; HYPNOTIC SEDATIVE AGENT; PIPERIDINE DERIVATIVE;

AIRWAY; AIRWAY OBSTRUCTION; FIBER OPTICS; HUMAN; HYPOXIA; INTUBATION; LETTER; OBESITY; RESPIRATION DEPRESSION; RISK ASSESSMENT; SCORING SYSTEM; SEDATION; CHEMICALLY INDUCED DISORDER; CONSCIOUS SEDATION; ENDOTRACHEAL INTUBATION; METHODOLOGY; NOTE; RESPIRATORY FAILURE;

CONSCIOUS SEDATION; FIBER OPTIC TECHNOLOGY; HUMANS; HYPNOTICS AND SEDATIVES; INTUBATION, INTRATRACHEAL; PIPERIDINES; RESPIRATORY INSUFFICIENCY;

EID: 59449100947     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2008.05839.x     Document Type: Letter

References (3)

1. Mingo OH, Ashpole KJ, Irving CJ, Rucklidge WM. Remifentanil sedation for awake fibreoptic intubation with limited application of local anaesthetic in patients for elective head and neck surgery. Anaesthesia 2008; 63:1065-9.
2. Sneyd JR. Remifentanil manual versus target-controlled infusion. Anesthesia and Analgesia 2003; 97: 300.
3. Puchner W, Obwegeser J, Puhringer FK. Use of remifentanil for awake fibreoptic intubation in a morbidly obese patient with severe inflammation of the neck. Acta Anaesthesiologica Scandinavica 2002; 46: 473-6.